6.14

2.85% -0.18

After Hours: 6.26 0.12 +1.95%

Journey Medical Corp (DERM)

Overview News Price History Financials Discussions Forecast

Journey Medical Corp stock is traded at $6.14, with a volume of 216.27K. It is down -2.85% in the last 24 hours and down -18.46% over the past month. Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Previous Close:

$6.32

Open:

$6.38

24h Volume:

216.27K

Relative Volume:

0.96

Market Cap:

$173.30M

Revenue:

$61.86M

Net Income/Loss:

$-11.43M

P/E Ratio:

-12.74

EPS:

-0.4818

Net Cash Flow:

$-12.52M

1W Performance:

-16.01%

1M Performance:

-18.46%

6M Performance:

-10.10%

1Y Performance:

-11.01%

1-Day Range:

$6.09

$6.43

1-Week Range:

$6.09

$7.525

52-Week Range:

$4.31

$9.555

Journey Medical Corp Stock (DERM) Company Profile

Name

Journey Medical Corp

Sector

Healthcare (1067)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

480-434-6670

Address

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

Employee

Twitter

Next Earnings Date

2026-11-11

Latest SEC Filings

DERM's Discussions on Twitter

Compare DERM vs TAK, TEVA, HLN, ZTS, VTRS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DERM Journey Medical Corp	6.14	173.30M	61.86M	-11.43M	-12.52M	-0.4818
TAK Takeda Pharmaceutical Co Adr	18.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.19	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.26	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	71.05	29.36B	9.51B	2.64B	2.14B	6.0361
VTRS Viatris Inc	17.83	20.48B	14.57B	-296.50M	1.64B	-0.259

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-25-25	Initiated	H.C. Wainwright	Buy
Jul-30-25	Resumed	B. Riley Securities	Buy
Aug-22-24	Initiated	Rodman & Renshaw	Buy
Jun-28-24	Resumed	ROTH MKM	Buy
Dec-07-21	Initiated	B. Riley Securities	Buy

Journey Medical Corp Stock (DERM) Latest News

Sep 21, 2026

AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI

Sep 21, 2026

Are Options Traders Betting on a Big Move in Journey Medical Stock? - Yahoo Finance

Sep 21, 2026

Sep 16, 2026

EOCN Should I Buy - Intellectia AI

Sep 16, 2026

Sep 14, 2026

Journey Medical at H.C. Wainwright: emrosi drives growth - Investing.com

Sep 14, 2026

Sep 11, 2026

Journey Medical Corporation $DERM Shares Sold by Opaleye Management Inc. - marketbeat.com

Sep 11, 2026

Sep 08, 2026

Journey Medical Corporation to Participate in September 2026 Investor Conferences - Yahoo Finance

Sep 08, 2026

Shinon Healthcare Receives Honors at Sanjeevani 2026 for Medical Value Travel Leadership, Advancing the 'Heal in India' Vision - indiagazette.com

Sep 08, 2026

Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan

Sep 08, 2026

Sep 05, 2026

DERM Should I Buy - Intellectia AI

Sep 05, 2026

Sep 04, 2026